CD24, CD27, CD36 and CD302 gene expression for outcome prediction in patients with multiple myeloma

por Alaterre, Elina, Raimbault, Sebastien, Goldschmidt, Hartmut, Bouhya, Salahedine, Requirand, Guilhem, Robert, Nicolas, Boireau, Stéphanie, Seckinger, Anja, Hose, Dirk, Klein, Bernard, Moreaux, Jérôme
Publicado 2017

Residual malignant and normal plasma cells shortly after high dose melphalan and stem cell transplantation. Highlight of a putative therapeutic window in Multiple Myeloma?

por Caraux, Anouk, Vincent, Laure, Bouhya, Salahedine, Quittet, Philippe, Moreaux, Jérôme, Requirand, Guilhem, Veyrune, Jean-Luc, Olivier, Gaëlle, Cartron, Guillaume, Rossi, Jean-François, Klein, Bernard
Publicado 2012

DNMTi/HDACi combined epigenetic targeted treatment induces reprogramming of myeloma cells in the direction of normal plasma cells

por Bruyer, Angelique, Maes, Ken, Herviou, Laurie, Kassambara, Alboukadel, Seckinger, Anja, Cartron, Guillaume, Rème, Thierry, Robert, Nicolas, Requirand, Guilhem, Boireau, Stéphanie, Müller-Tidow, Carsten, Veyrune, Jean-luc, Vincent, Laure, Bouhya, Salahedine, Goldschmidt, Hartmut, Vanderkerken, Karin, Hose, Dirk, Klein, Bernard, De Bruyne, Elke, Moreaux, Jerome
Publicado 2018